Trial Profile
A phase I study of TAK-792 for obesity
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2017
Price :
$35
*
At a glance
- Drugs Sucunamostat (Primary)
- Indications Obesity
- Focus Adverse reactions
- 15 Mar 2017 New trial record